vs

Side-by-side financial comparison of Ivanhoe Electric Inc. (IE) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $896.0K, roughly 2.0× Ivanhoe Electric Inc.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -4500.4%, a 4349.9% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs -32.7%). INVO Fertility, Inc. produced more free cash flow last quarter ($-1.8M vs $-25.7M). Over the past eight quarters, Ivanhoe Electric Inc.'s revenue compounded faster (57.8% CAGR vs 12.8%).

Ivanhoe Electric Inc. is a critical minerals exploration and development firm focused on metals for global electrification. It targets high-grade copper, gold, silver and strategic deposits, with primary North American operations, supplying raw materials to renewable energy, EV and power grid infrastructure supply chains worldwide.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

IE vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
2.0× larger
IVF
$1.8M
$896.0K
IE
Growing faster (revenue YoY)
IVF
IVF
+55.3% gap
IVF
22.6%
-32.7%
IE
Higher net margin
IVF
IVF
4349.9% more per $
IVF
-150.5%
-4500.4%
IE
More free cash flow
IVF
IVF
$24.0M more FCF
IVF
$-1.8M
$-25.7M
IE
Faster 2-yr revenue CAGR
IE
IE
Annualised
IE
57.8%
12.8%
IVF

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IE
IE
IVF
IVF
Revenue
$896.0K
$1.8M
Net Profit
$-40.3M
$-2.6M
Gross Margin
69.5%
Operating Margin
-4167.7%
-93.1%
Net Margin
-4500.4%
-150.5%
Revenue YoY
-32.7%
22.6%
Net Profit YoY
-318.3%
-62.2%
EPS (diluted)
$0.24
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IE
IE
IVF
IVF
Q4 25
$896.0K
Q3 25
$545.0K
$1.8M
Q2 25
$1.1M
$1.9M
Q1 25
$735.0K
$1.6M
Q4 24
$1.3M
$1.7M
Q3 24
$671.0K
$1.4M
Q2 24
$538.0K
$1.8M
Q1 24
$360.0K
$1.6M
Net Profit
IE
IE
IVF
IVF
Q4 25
$-40.3M
Q3 25
$-17.5M
$-2.6M
Q2 25
$-23.9M
$-5.3M
Q1 25
$-34.1M
$-17.4M
Q4 24
$18.5M
$-3.6M
Q3 24
$-43.2M
$-1.6M
Q2 24
$-46.8M
$-2.2M
Q1 24
$-60.1M
$-1.6M
Gross Margin
IE
IE
IVF
IVF
Q4 25
69.5%
Q3 25
51.2%
Q2 25
72.5%
Q1 25
60.1%
35.2%
Q4 24
64.7%
41.4%
Q3 24
61.8%
31.0%
Q2 24
64.3%
53.1%
Q1 24
72.2%
45.3%
Operating Margin
IE
IE
IVF
IVF
Q4 25
-4167.7%
Q3 25
-4328.3%
-93.1%
Q2 25
-2400.3%
-160.4%
Q1 25
-3674.0%
-1042.1%
Q4 24
-2229.4%
-202.0%
Q3 24
-6233.8%
-90.7%
Q2 24
-9023.4%
-100.9%
Q1 24
-15800.3%
-95.7%
Net Margin
IE
IE
IVF
IVF
Q4 25
-4500.4%
Q3 25
-3214.9%
-150.5%
Q2 25
-2233.2%
-283.6%
Q1 25
-4645.0%
-1060.1%
Q4 24
1386.6%
-211.3%
Q3 24
-6443.5%
-113.8%
Q2 24
-8695.7%
-122.2%
Q1 24
-16693.1%
-101.3%
EPS (diluted)
IE
IE
IVF
IVF
Q4 25
$0.24
Q3 25
$0.13
$-0.77
Q2 25
$0.18
$-13.30
Q1 25
$0.24
$-12.53
Q4 24
$-0.14
$14.86
Q3 24
$0.36
$-15.11
Q2 24
$0.39
$-22.39
Q1 24
$0.46
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IE
IE
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$173.3M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$416.1M
$5.8M
Total Assets
$483.3M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IE
IE
IVF
IVF
Q4 25
$173.3M
Q3 25
$69.5M
Q2 25
$88.0M
Q1 25
$98.2M
Q4 24
$41.0M
Q3 24
$81.1M
Q2 24
$133.8M
Q1 24
$179.4M
Total Debt
IE
IE
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IE
IE
IVF
IVF
Q4 25
$416.1M
Q3 25
$280.1M
$5.8M
Q2 25
$293.3M
$2.6M
Q1 25
$307.0M
$3.3M
Q4 24
$268.6M
$12.7M
Q3 24
$250.1M
$-23.3K
Q2 24
$289.2M
$1.4M
Q1 24
$331.5M
$10.2K
Total Assets
IE
IE
IVF
IVF
Q4 25
$483.3M
Q3 25
$386.2M
$18.8M
Q2 25
$400.5M
$19.3M
Q1 25
$414.4M
$31.7M
Q4 24
$374.9M
$46.4M
Q3 24
$375.4M
$17.0M
Q2 24
$416.3M
$17.8M
Q1 24
$461.2M
$17.3M
Debt / Equity
IE
IE
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IE
IE
IVF
IVF
Operating Cash FlowLast quarter
$-25.7M
$-1.8M
Free Cash FlowOCF − Capex
$-25.7M
$-1.8M
FCF MarginFCF / Revenue
-2872.8%
-101.6%
Capex IntensityCapex / Revenue
4.1%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-90.6M
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IE
IE
IVF
IVF
Q4 25
$-25.7M
Q3 25
$-27.7M
$-1.8M
Q2 25
$-20.0M
$-1.7M
Q1 25
$-15.8M
$-3.5M
Q4 24
$-30.7M
$-617.4K
Q3 24
$-36.9M
$-640.8K
Q2 24
$-44.5M
$-1.5M
Q1 24
$-50.0M
$-260.6K
Free Cash Flow
IE
IE
IVF
IVF
Q4 25
$-25.7M
Q3 25
$-27.8M
$-1.8M
Q2 25
$-21.3M
$-1.7M
Q1 25
$-15.8M
$-3.6M
Q4 24
$-32.4M
$-696.3K
Q3 24
$-36.9M
Q2 24
$-45.0M
$-1.5M
Q1 24
$-50.6M
$-310.3K
FCF Margin
IE
IE
IVF
IVF
Q4 25
-2872.8%
Q3 25
-5103.9%
-101.6%
Q2 25
-1990.1%
-92.6%
Q1 25
-2146.5%
-216.9%
Q4 24
-2432.4%
-40.6%
Q3 24
-5506.6%
Q2 24
-8372.9%
-82.3%
Q1 24
-14064.2%
-19.7%
Capex Intensity
IE
IE
IVF
IVF
Q4 25
4.1%
Q3 25
16.9%
0.5%
Q2 25
117.6%
0.5%
Q1 25
0.3%
0.9%
Q4 24
127.3%
4.6%
Q3 24
8.8%
0.0%
Q2 24
93.7%
3.0%
Q1 24
186.7%
3.2%
Cash Conversion
IE
IE
IVF
IVF
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.66×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons